FGF-23 Antibody (C-term 225-244)
A goat polyclonal antibody to human FGF-23.
Product Specifications
Citations | 7 |
---|---|
Clonality |
Polyclonal |
Immunogen | Synthetic peptide corresponding to amino acids 225-244 of human FGF-23 |
Applications | See citations and technical data sheet for application info. |
Concentration | Varies (refer to CoA) |
Conjugate | Unconjugated |
Cross Reactivity |
None |
Ordering Information
Catalog Number | 21-6120 |
---|---|
Catalog Number (CE) | N/A |
Size | 100 µg |
Price (USD) | $385.00 |
Price (EURO) | 340,00 € |
Contact us
US Phone | +1 (858) 552 1100 |
---|---|
EU Phone | +353 (91) 412 474 |
US Email | contact-us@quidelortho.com |
EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
Description |
A goat polyclonal antibody to human FGF-23. |
---|---|
Size | 100 µg |
Concentration |
Varies (refer to CoA) |
Applications | See citations and technical data sheet for application info. |
Form | Liquid. 0.01M PBS (pH 7.4 ± 0.2), with 0.1% Sodium Azide. |
Clonality | Polyclonal |
Immunogen | Synthetic peptide corresponding to amino acids 225-244 of human FGF-23 |
Conjugate | Unconjugated |
Cross Reactivity | None |
Isotype | Goat IgG |
Purity | Affinity purified |
Source |
Goat |
Specificity | The specificity of the antibody was established via series of immunoassays. |
Storage |
Short term (30 days) 4˚C. Long term at or below –20˚C. |
Background |
Fibroblast growth factor 23 (FGF-23), which is produced by bone cells, is a novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins. |
Citations
Title | Year | Applications | Sample Species | Sample | Sample Details |
---|---|---|---|---|---|
2019 | IHC |
Human |
Neurofibromas |
||
2019 | IHC |
Human |
Skin Tissue |
||
FGF23 protein expression in coronary arteries is associated with impaired kidney function |
2014 | IHC |
Human |
Artery Tissue |
|
Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients |
2015 | IHC, WB |
Human |
Bone Tissue |
|
Biological variability of plasma intact and C-terminal FGF23 measurements |
2012 | IP, WB |
Human |
Plasma |
|
2010 | WB |
Human |
Plasma |
||
Biological variability of plasma intact and C-terminal FGF23 measurements |
2012 | WB |
Human |
Plasma |